It is intended for FDA personnel and is available electronically to the public. The regulation also defines certain benefits that do not constitute monetary payment. The requirement that the label of a blood product indicate whether the product came from a volunteer or a paid donor applies only to blood and blood components intended for transfusion. It does not apply to products that will be used for further manufacturing, such as Source Plasma. These products include Whole Blood, Red Blood Cells, Fresh Frozen Plasma, and Platelets.
Monetary payment includes cash, in any amount, or items that are readily convertible to cash.
If the donor receives an incentive other than cash, the incentive must be evaluated to determine if it is readily convertible to cash. These incentives are not considered to be readily convertible to cash. If the incentive is not transferable, it can only benefit the donor. The dollar value of the incentive and the nature of the population attracted by it are not relevant. It is also not relevant if the incentive goes only to donors who are successful in donating or if all donors who present to donate receive the incentive.